322 related items for PubMed ID: 26530040
1. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study.
Takahashi T, Sakakibara H, Morikawa Y, Miura M.
Pediatr Rheumatol Online J; 2015 Nov 04; 13(1):44. PubMed ID: 26530040
[Abstract] [Full Text] [Related]
2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 04; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
3. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Yamashita M, Ae R, Yashiro M, Aoyama Y, Sano T, Makino N, Nakamura Y.
Pediatr Cardiol; 2017 Feb 04; 38(2):375-380. PubMed ID: 27878631
[Abstract] [Full Text] [Related]
4. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 04; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
5. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
6. Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.
Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Matsubara Y, Matsubara D, Kosami K, Sasahara T, Belay ED.
Am Heart J; 2020 Jul 21; 225():120-128. PubMed ID: 32497905
[Abstract] [Full Text] [Related]
7. [Clinical analysis of 942 cases of Kawasaki disease].
Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q, Yang XQ.
Zhonghua Er Ke Za Zhi; 2006 May 21; 44(5):324-8. PubMed ID: 16780705
[Abstract] [Full Text] [Related]
8. Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease.
Yoshida M, Oana S, Masuda H, Ishiguro A, Kato H, Ito S, Kobayashi T, Abe J.
Clin Pediatr (Phila); 2018 Feb 21; 57(2):189-192. PubMed ID: 28952328
[Abstract] [Full Text] [Related]
9. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec 21; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
10. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May 21; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
11. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
Kaohsiung J Med Sci; 2012 Jan 21; 28(1):23-9. PubMed ID: 22226058
[Abstract] [Full Text] [Related]
12. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J, Liu P, Hu W, Xu Y, Deng J.
Clin Rheumatol; 2021 Oct 21; 40(10):4191-4197. PubMed ID: 34059986
[Abstract] [Full Text] [Related]
13. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
14. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
Zhao CN, Du ZD, Gao LL.
Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036
[Abstract] [Full Text] [Related]
15. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 20; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
16. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
Zhang X, He Y, Shao Y, Hang B, Xu Z, Chu M.
Pediatr Rheumatol Online J; 2021 Jun 26; 19(1):96. PubMed ID: 34174872
[Abstract] [Full Text] [Related]
17. Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC, Corsello G, Prinzi E, Cimaz R.
Ital J Pediatr; 2016 Nov 02; 42(1):92. PubMed ID: 27806720
[Abstract] [Full Text] [Related]
18. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.
J Microbiol Immunol Infect; 2007 Oct 02; 40(5):395-400. PubMed ID: 17932598
[Abstract] [Full Text] [Related]
19. Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days.
Hu YC, Liu HM, Lin MT, Chen CA, Chiu SN, Lu CW, Chang LY, Wang JK, Wu MH.
Front Pediatr; 2019 Oct 02; 7():158. PubMed ID: 31069204
[Abstract] [Full Text] [Related]
20. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Oct 02; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
